JP2022537736A5 - - Google Patents
Info
- Publication number
- JP2022537736A5 JP2022537736A5 JP2021575056A JP2021575056A JP2022537736A5 JP 2022537736 A5 JP2022537736 A5 JP 2022537736A5 JP 2021575056 A JP2021575056 A JP 2021575056A JP 2021575056 A JP2021575056 A JP 2021575056A JP 2022537736 A5 JP2022537736 A5 JP 2022537736A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- antigen
- antibody
- seq
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19183405.0 | 2019-06-28 | ||
| EP19183405.0A EP3757125A1 (en) | 2019-06-28 | 2019-06-28 | Antibody directed against the apoe amino-terminal fragment of 12 kda |
| PCT/EP2020/067890 WO2020260491A2 (en) | 2019-06-28 | 2020-06-25 | New antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022537736A JP2022537736A (ja) | 2022-08-29 |
| JP2022537736A5 true JP2022537736A5 (https=) | 2023-06-29 |
Family
ID=67225987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021575056A Pending JP2022537736A (ja) | 2019-06-28 | 2020-06-25 | １２ｋＤａのＡｐｏＥアミノ末端断片に対する抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220242939A1 (https=) |
| EP (2) | EP3757125A1 (https=) |
| JP (1) | JP2022537736A (https=) |
| KR (1) | KR20220029653A (https=) |
| CN (1) | CN114008074A (https=) |
| AU (1) | AU2020304855A1 (https=) |
| BR (1) | BR112021025956A2 (https=) |
| CA (1) | CA3140999A1 (https=) |
| IL (1) | IL289271A (https=) |
| MX (1) | MX2021016160A (https=) |
| WO (1) | WO2020260491A2 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5168045A (en) * | 1989-08-18 | 1992-12-01 | The Scripps Research Institute | Diagnostic systems and methods using polypeptide analogs of apolipoprotein e |
| NZ581835A (en) * | 2007-06-12 | 2012-09-28 | Ac Immune Sa | Monoclonal anti beta amyloid antibody |
| JP2009092550A (ja) * | 2007-10-10 | 2009-04-30 | Japan Health Science Foundation | うつ病またはうつ状態の同定方法 |
| CN102459335B (zh) * | 2009-04-17 | 2015-11-25 | 伊缪纳斯制药株式会社 | 特异性结合Aβ寡聚体的抗体及其用途 |
| WO2011084714A2 (en) * | 2009-12-17 | 2011-07-14 | Biogen Idec Ma Inc. | STABILIZED ANTI-TNF-ALPHA scFv MOLECULES OR ANTI-TWEAK scFv MOLECULES AND USES THEREOF |
| US20170218058A1 (en) * | 2016-01-28 | 2017-08-03 | Alector, LLC | Anti-apoe4 antigen-binding proteins and methods of use thereof |
| US20190224339A1 (en) * | 2016-04-29 | 2019-07-25 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| WO2018137705A1 (en) * | 2017-01-26 | 2018-08-02 | Zai Lab (Shanghai) Co., Ltd. | Cd47 antigen binding unit and uses thereof |
-
2019
- 2019-06-28 EP EP19183405.0A patent/EP3757125A1/en not_active Withdrawn
-
2020
- 2020-06-25 KR KR1020227000512A patent/KR20220029653A/ko active Pending
- 2020-06-25 MX MX2021016160A patent/MX2021016160A/es unknown
- 2020-06-25 WO PCT/EP2020/067890 patent/WO2020260491A2/en not_active Ceased
- 2020-06-25 AU AU2020304855A patent/AU2020304855A1/en not_active Abandoned
- 2020-06-25 CN CN202080045874.2A patent/CN114008074A/zh active Pending
- 2020-06-25 CA CA3140999A patent/CA3140999A1/en active Pending
- 2020-06-25 JP JP2021575056A patent/JP2022537736A/ja active Pending
- 2020-06-25 BR BR112021025956A patent/BR112021025956A2/pt unknown
- 2020-06-25 EP EP20734930.9A patent/EP3990486A2/en active Pending
- 2020-06-25 US US17/617,469 patent/US20220242939A1/en not_active Abandoned
-
2021
- 2021-12-22 IL IL289271A patent/IL289271A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105849124B (zh) | 双重特异性抗体 | |
| JP2018108081A5 (https=) | ||
| CA2838246C (en) | Antibodies against g-csfr and uses thereof | |
| JP6513657B2 (ja) | Ｉｌ−１７ａ結合剤およびその用途 | |
| JP2021159081A5 (https=) | ||
| NZ717476A (en) | Anti-garp protein and uses thereof | |
| WO2019091436A1 (zh) | 4-1bb抗体及其制备方法和应用 | |
| JP2019533719A5 (https=) | ||
| JP2022104966A (ja) | ａ－ｓｙｎ／ＩＧＦ１Ｒに対する二重特異抗体およびその用途 | |
| JP2022512234A5 (https=) | ||
| JP2025063183A5 (https=) | ||
| JP2022513043A5 (https=) | ||
| JP2019507580A5 (https=) | ||
| CN113583116A (zh) | 针对SARS-CoV-1或SARS-CoV-2的抗体及其用途 | |
| JP2019505166A5 (https=) | ||
| JP2026004299A5 (https=) | ||
| JP2020515277A5 (https=) | ||
| CN106456732A (zh) | 结合wisp1的抗体疗法 | |
| JP2020522475A5 (https=) | ||
| JP2022548646A5 (https=) | ||
| CN104011206A (zh) | 新型抗人ctgf抗体 | |
| JP2023551981A5 (https=) | ||
| CN112601550B (zh) | 抗-乙型淀粉样蛋白抗体及其用途 | |
| JP2022537736A5 (https=) | ||
| JP2023551983A5 (https=) |